Clinical Trials · NCT01982760

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

TerminatedPhase 2Desmopressin (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
University Hospitals Cleveland Medical Center
Enrollment
14
Start date
Dec 2013
Locations
1 site, United States
Primary endpoint
Reduction in Ecchymosis and Swelling
View Desmopressin compound reference